Latest Rosiglitazone Stories
Treatment with the glitazone class of diabetes drugs leads to a "modest" increase in the risk of diabetic macular edema (DME)â€”a common complication that can lead to vision loss
Federal health officials are examining a potentially ground breaking diabetes medication from Bristol-Myers Squibb because it appears free of heart-related side effects that have plagued similar treatments.
NEW YORK, Feb.
Basis Established for DNA-Guided Decision Support in Diabetes Drug Therapy HARTFORD, Conn., Jan.
LOS ALTOS, Calif., Jan. 8 /PRNewswire/ -- InteKrin Therapeutics, Inc., will present at the 27th Annual JP Morgan Global Healthcare Conference at 9:00 a.m. Pacific Time on Tuesday, January 13, 2009, to be held at the Westin St. Francis in San Francisco, California.
A study released on Wednesday shows that long-term use of GlaxoSmithKline's Avandia and Takeda's Actos doubles the risk of bone fractures in women with type 2 diabetes.
A medication for diabetics may do more harm than good. Doctors are concerned rosiglitazone may increase older patients' risk of death and heart failure.A black box warning was recently added to two drugs, rosiglitazone and pioglitazone hydrochloride, cautioning patients with heart failure against using them. Recent studies have shown the risks linked to rosiglitazone are even greater than those associated with pioglitazone.Researchers at Brigham and Women's Hospital and Harvard Medical School...
New findings support the claim that a controversial diabetes pill failed to significantly slow plaque buildup in heart arteries compared with an older drug.
Public Citizen, a consumer advocate group, has called on the US to ban sales and distribution of the diabetes drug Avandia due to certain risks found to be linked with the drug.